Prevalence of Pneumocystis jirovecii colonization in autopsy cases in Turkey

Soykan Özkoç1, Murat Köker2, Mustafa Önder2

  • 1Department of Parasitology, Dokuz Eylül University, Faculty of Medicine, Izmir, Turkey.

Insights

Pneumocystis jirovecii colonization was detected in 18.5% of asymptomatic individuals. Infants and those with chronic diseases showed higher colonization rates, suggesting increased risk.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Pneumocystis jirovecii colonization, defined as its DNA detection in asymptomatic individuals, is a growing concern.
  • Understanding colonization prevalence in immunocompetent populations is crucial for public health strategies.

Purpose of the Study:

  • To determine the prevalence of Pneumocystis jirovecii colonization in an immunocompetent population.
  • To identify factors associated with P. jirovecii colonization in this demographic.

Main Methods:

  • Nested PCR targeting the mitochondrial large subunit rRNA gene was employed.
  • DNA was extracted from lung tissue specimens of 200 individuals undergoing forensic autopsy.
  • Cases were categorized based on cause of death: non-medical, medical, and undetermined.

Main Results:

  • Pneumocystis jirovecii DNA was detected in 18.5% (37/200) of the studied cases.
  • Significantly higher colonization rates were observed in cases with medical causes of death (P=0.022).
  • Infants aged 0-1 year (45.5%) and individuals with chronic diseases (particularly cardiac or pulmonary) showed elevated colonization rates.

Conclusions:

  • The study highlights a significant prevalence of P. jirovecii colonization in immunocompetent individuals.
  • Infants and patients with chronic conditions represent at-risk groups for P. jirovecii colonization.
  • Further research into risk factors and clinical implications of colonization in these populations is warranted.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K